Advertising feature from Kite, a Gilead company

Vision launched in UK to maintain leadership position in cell and gene therapies

From our UK edition

Cell and gene therapies are advanced medical treatments for certain patients with debilitating or life-shortening diseases. They work by either altering the content of a person’s genetic code, or by replacing diseased or dysfunctional cells with healthy ones. The UK was the first country in Europe to reach agreements that would see some patients routinely